BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vij M, Rammohan A, Rela M. Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection. World J Hepatol 2022; 14(8): 1541-1549 [PMID: 36157865 DOI: 10.4254/wjh.v14.i8.1541]
URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1541.htm
Number Citing Articles
1
Hanlin L. Wang. Asymptomatic Allograft Fibrosis in Pediatric Liver Transplantation: Potential Clinical ImplicationsTransplantation 2023; 107(11): 2314 doi: 10.1097/TP.0000000000004604
2
Mebrahtu G. Tedla, Mebrihit M. Kahsay, Mebrahtu G. Kidanu. Maintaining the optimum level of immunosuppressive agents minimizes risk of liver allograft fibrosis during pediatric liver transplantationInternational Journal of Surgery 2024; 110(6): 3946 doi: 10.1097/JS9.0000000000000759
3
Shilpa Chawla, Subholakshmi Choudhury, Amitava Das. Bioengineered MSCGFPCxcr2-Mmp13 Transplantation Alleviates Hepatic Fibrosis by Regulating Mammalian Target of Rapamycin SignalingAntioxidants & Redox Signaling 2024; 41(1-3): 110 doi: 10.1089/ars.2023.0390
4
Samuele Iesari, Francesca Laura Nava, Ilaria Elena Zais, Laurent Coubeau, Mariano Ferraresso, Evaldo Favi, Jan Lerut. Advancing immunosuppression in liver transplantation: A narrative reviewHepatobiliary & Pancreatic Diseases International 2024; 23(5): 441 doi: 10.1016/j.hbpd.2024.03.001
5
Toshiaki Nakano, Shigeru Goto, Chao-Long Chen. Mechanisms of Tolerance Induction in Liver Transplantation: Lessons Learned from Fetomaternal Tolerance, Autoimmunity and Tumor ImmunityInternational Journal of Molecular Sciences 2024; 25(17): 9331 doi: 10.3390/ijms25179331
6
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantationPortal Hypertension & Cirrhosis 2024; 3(1): 22 doi: 10.1002/poh2.70
7
Djordje Milosevic, Marija Brankovic, Mihailo Jovanovic, Janko Djordjevic, Nenad Grujovic, Fatima Zivic. Design of the Amorphous Solid Dispersion (Asd) Drugs by Hot Melt Extrusion (Hme), for the Inhibition of Bone Graft Rejection2024 IEEE 24th International Conference on Bioinformatics and Bioengineering (BIBE) 2024; : 1 doi: 10.1109/BIBE63649.2024.10820476
8
Madhumitha Rabindranath, Rita Zaya, Khairunnadiya Prayitno, Ani Orchanian-Cheff, Keyur Patel, Elmar Jaeckel, Mamatha Bhat. A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to DiagnosisTransplantation Direct 2023; 9(11): e1547 doi: 10.1097/TXD.0000000000001547
9
S. E. Voskanyan, V. E. Syutkin, A. I. Sushkov, Yu. V. Voskanyan, A. Yu. Veselkova. Liver allograft pathology in the late post-transplant periodTransplantologiya. The Russian Journal of Transplantation 2023; 15(3): 359 doi: 10.23873/2074-0506-2023-15-3-359-375
10
Man Luo, Jiapeng Yang, Kai Zhang, Ji Sun, Zhiyu Lu, Zhihao Wang, Yaowei Hu, Jianxin Zhai, Peng Xie, Tana Siqin, Mengran Lang, Xuan Meng, Hongguang Wang. Current advance in comprehensive management of hilar cholangiocarcinoma and navigation in surgery: non-systematic reviewsInternational Journal of Surgery 2025; 111(2): 2131 doi: 10.1097/JS9.0000000000002206
11
Nourhan Badwei. Hepatic allograft rejection after liver transplantation: Clinicopathological debates!iLIVER 2023; 2(2): 116 doi: 10.1016/j.iliver.2023.05.003